ERIS

HealthcareDrug Manufacturers - Specialty & GenericLarge Cap
Eris Lifesciences Limited

Eris Lifesciences Limited (ERIS) is a healthcare company operating in the Drug Manufacturers - Specialty & Generic sub-sector. It provides domestic branded formulations for chronic...

हिन्दी में

Eris Lifesciences Limited (ERIS) हेल्थकेयर क्षेत्र की एक कंपनी है, जो विशिष्ट और जेनेरिक दवा निर्माताओं के उप-क्षेत्र में काम करती है। यह भारत और अंतरराष्ट्रीय स्तर पर क्रोनिक और स...

₹1,170.7+1.35%1D
Previous trading day close · Data updates after market close
1W: -1.5%
1M: -12.3%
6M: -14.6%
1Y: -26.5%
67/100
AverageResearch Score
Market Cap
₹20.2K Cr
Large Cap
P/E Ratio
32.01
Fair
P/B Ratio
6.06
Premium
ROE
10.8%
Weak
ROCE
15.5%
Good
Debt / Equity
0.76
Moderate
Div. Yield
0.5%
EV/EBITDA
20.26
Fair
52W Low: ₹1,141Current: ₹1,170.752W High: ₹1,740
At 5% of 52-week range
Data as of previous trading day close · Updated after market close
📉 Full Technical Chart (RSI, MACD, ADX)
📊
Loading chart...
── Price── SMA50── SMA200Data: Previous trading day close · Updated after market close
Research Score Breakdown
5-factor fundamental analysis — not a buy/sell signal
Quality
ROE, ROCE, margins, cash flow
70/100
Growth
Revenue, EPS, profit growth
87/100
Valuation
PE, PB, EV/EBITDA vs sector
41/100
Risk
Debt levels, volatility, coverage
76/100
News Sentiment
Recent news sentiment
50/100
Weightage: Quality 30% + Growth 25% + Valuation 20% + Risk 15% + News 10%
Mathematical score — not investment advice
Valuation Ratios
P/E Ratio
32.01(Fair)
Forward P/E
30.51(Premium)
P/B Ratio
6.06(Premium)
P/S Ratio
6.32(Expensive)
EV/EBITDA
20.26(Expensive)
Dividend Yield
0.5%
5Y CAGR
13.5%(Moderate)
Revenue Growth
7.2%(Moderate)
Profitability
ROE
10.8%(Average)
ROCE
15.5%(Good)
ROA
5.2%(Average)
Net Margin
19.7%(High)
EBITDA Margin
35.4%
Financial Health
Debt to Equity
0.76(Moderate)
Current Ratio
0.89(Tight)
Quick Ratio
0.64(Tight)
Interest Coverage
4.31x(Comfortable)
Technical Indicators
Based on previous trading day close
RSI (14)
14(Oversold)
RSI Exp (14)
18(Oversold)
MACD
-44.609(Bearish)
MACD Signal
-36.584
BB Position
20%(Lower band)
BB Width
21.22%(High volatility)
ADX (14)
46.9(Strong trend)
Williams %R
-84.4(Oversold)
MFI (14)
8(Oversold)
CCI (20)
-105(Oversold)
Stoch %K
16(Oversold)
ATR (14)
42.18(Avg True Range)
OBV (M)
21.7(Positive)
1W OBV Chg
1.1%(Increasing)
Rel Volume
0.73x(Normal)
Volatility
32.6%(Moderate)
Max DD 1Y
-38.0%(Moderate)
EMA 200
1383.3
EMA 50
1291.2
SMA 200
1378.4
vs SMA 50
-10.3%(Below SMA50)
vs SMA 200
-15.1%(Below SMA200)
Volume
72.4K
Avg Vol 3M
1.0L
Shareholding Pattern
Promoter
53.9%
High confidence
FII
6.4%
DII / MF
20.4%
Strong MF interest
Share ERIS
Share this stock analysis with your network
𝕏 Share on XWhatsAppLinkedIn
⚠️ Research Score is a mathematical fundamental score — not investment advice. Data updates after market close. Please consult a SEBI-registered advisor before investing.
Eris Lifesciences Limited (ERIS) Share Price ₹1170.70 Today | StockSage Pro